Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages

Thursday, February 9, 2012 - 10:00am
2123 Rayburn
Background Documents and Information: 
Witnesses: 

Panel I 

 

Dr. Janet Woodcock


Panel II


 


Ms. Heather Bresch


Mr. David Gaugh



Mr. Bill Greene, Pharm. D., BCPS, FASHP

  • 
Chief Pharmaceutical Officer

  • Pharmaceutical Services

  • Member, Pharmaceutical Sciences

  • St. Jude Children’s Research Hospital

  • Witness Testimony (Truth in Testimony)
Congress: